Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery

Journal of Cancer Survivorship

Volumn 9, Issue 2, 2015, Pages 172-179

  Dahl, Sigrun ^a   Loge, Jon Håvard ^a   Berge, Viktor ^a   Dahl, Alv Andreas ^a   Cvancarova, Milada ^a   Fosså, Sophie Dorothea ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adverse effects; Prostate cancer; Radical prostatectomy; Work participation

Indexed keywords

AGED; EMPLOYMENT; HUMAN; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROSPECTIVE STUDY; PROSTATECTOMY; PROSTATIC NEOPLASMS; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; REHABILITATION; STATISTICS AND NUMERICAL DATA; SURVIVOR; WORK;

AGED; EMPLOYMENT; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; SURVIVORS; WORK;

EID: 84929990954     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-014-0399-6     Document Type: Article

References (34)

1. Amir Z, Moran T, Walsh L, Iddenden R, Luker K. Return to paid work after cancer: a British experience. J Cancer Surviv. 2007;1(2):129–36.
2. Spelten ER, Verbeek JHAM, Uitterhoeve ALJ, Ansink AC, van der Lelie J, de Reijke TM, et al. Cancer, fatigue and the return of patients to work—a prospective cohort study. Eur J Cancer. 2003;39(11):1562–7.
3. Guidelines on prostate cancer. http://www.uroweb.org/gls/pdf/08%20Prostate%20Cancer_LR%20March%2013th%202012.pdf.2013
4. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250–61.
5. Stensvold A, Dahl AA, Brennhovd B, Smastuen MC, Fossa SD, Lilleby W, et al. Bother problems in prostate cancer patients after curative treatment. Urol Oncol 2012 Feb 16
6. Dahl S, Steinsvik EA, Dahl AA, Loge JH, Cvancarova M, Fossa SD. Return to work and sick leave after radical prostatectomy: a prospective clinical study. Acta Oncol 2013 Nov 6.
7. Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fossa SD. Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother. BJU Int. 2012;109(9):1366–74.
8. Ilmarinen J, Tuomi K, Klockars M. Changes in the work ability of active employees over an 11-year period. Scand J Work Environ Health. 1997;23 Suppl 1:49–57.
9. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969–74.
10. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273(2):129–35.
11. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899–905.
12. Statistics Norway. Levekårsundersøkelsen 2002. 2014. Ref Type: Unpublished Work
13. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. Int Qual Life Assess J Clin Epidemiol. 1998;51(11):1171–8.
14. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147–53.
15. Nordby P, Nerland SM, Næsheim H. Yrkesaktivitet blant eldre før og etter pensjonsreformen. Statistics Norway 2014
16. Wold M.G, Håland I. Eldre i arbeidslivet. Statistics Norway 2014
17. Bradley CJ, Neumark D, Luo Z, Bednarek H, Schenk M. Employment outcomes of men treated for prostate cancer. J Natl Cancer Inst. 2005;97(13):958–65.
18. Bradley CJ, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Invest. 2007;25(1):47–54.
19. Oberst K, Bradley CJ, Gardiner JC, Schenk M, Given CW. Work task disability in employed breast and prostate cancer patients. J Cancer Surviv Res Pract. 2010;4(4):322–30.
20. Mols F, Thong MS, Vreugdenhil G, van de Poll-Franse LV. Long-term cancer survivors experience work changes after diagnosis: results of a population-based study. Psychooncology. 2009;18(12):1252–60.
21. Torp S, Nielsen RA, Gudbergsson SB, Fossa SD, Dahl AA. Sick leave patterns among 5-year cancer survivors: a registry-based retrospective cohort study. J Cancer Surviv. 2012;6(3):315–23.
22. Maunsell E, Drolet M, Brisson J, Brisson C, Masse B, Deschenes L. Work situation after breast cancer: results from a population-based study. J Natl Cancer Inst. 2004;96(24):1813–22.
23. Duijts S, Egmond M, Spelten E, van Muijen P, Anema J, van der Beek A. Physical and psychosocial problems in cancer survivors beyond return to work: a systematic review. Psycho-Oncology. 2013;22:327–8.
24. Gore JL, Gollapudi K, Bergman J, Kwan L, Krupski TL, Litwin MS. Correlates of bother following treatment for clinically localized prostate cancer. J Urol. 2010;184(4):1309–15.
25. Madalinska JB, Essink-Bot ML, de Koning HJ, Kirkels WJ, van der Maas PJ, Schroder FH. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol. 2001;19(6):1619–28.
26. Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Chen VW, Cooperberg MR, et al. Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: defining the population at risk for harms of prostate cancer treatment. Cancer 2014 Feb 7.
27. Irwin DE, Milsom I, Kopp Z, Abrams P, Cardozo L. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int. 2006;97(1):96–100.
28. Grunfeld EA, Drudge-Coates L, Rixon L, Eaton E, Cooper AF. “The only way I know how to live is to work”: a qualitative study of work following treatment for prostate cancer. Health Psychol. 2013;32(1):75–82.
29. Cella D, Davis K, Breitbart W, Curt G. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001;19(14):3385–91.
30. Kyrdalen AE, Dahl AA, Hernes E, Cvancarova M, Fossa SD. Fatigue in hormone-naive prostate cancer patients treated with radical prostatectomy or definitive radiotherapy. Prostate Cancer Prostatic Dis. 2010;13(2):144–50.
31. Kyrdalen AE, Dahl AA, Hernes E, Hem E, Fossa SD. Fatigue in prostate cancer survivors treated with definitive radiotherapy and LHRH analogs. Prostate. 2010;70(13):1480–9.
32. Langston B, Armes J, Levy A, Tidey E, Ream E. The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature. Support Care Cancer. 2013;21(6):1761–71.
33. Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–30.
34. Iversen P, Mcleod DG, See WA, Morris T, Armstrong J, Wirth MP. Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years. BJU Int. 2010;105(8):1074–81.